Progression and remission of renal disease in the lupus nephritis collaborative study: Results of treatment with prednisone and short-term oral cyclophosphamide

Annals of Internal Medicine

Volumn 116, Issue 2, 1992, Pages 114-123

  Levey, Andrew S ^a   Lan, Shu Ping ^b   Corwin, Howard L ^c   Kasinath, Balakuntalam S ^d   Lachin, John ^b   Neilson, Eric G ^e   Hunsicker, Lawrence G ^f   Lewis, Edmund J ^g  

^a TUFTS MEDICAL CENTER   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^g RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYCLOPHOSPHAMIDE; PREDNISONE; PROTEIN;

ADOLESCENT; ADULT; COMPLEMENT BLOOD LEVEL; CONFERENCE PAPER; CREATININE BLOOD LEVEL; DISEASE COURSE; FEMALE; HUMAN; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORAL DRUG ADMINISTRATION; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; RISK FACTOR;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; COMBINED MODALITY THERAPY; CREATININE; CYCLOPHOSPHAMIDE; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HUMAN; KIDNEY FAILURE, CHRONIC; LUPUS NEPHRITIS; MALE; MIDDLE AGE; PLASMAPHERESIS; PREDNISONE; PROGNOSIS; REMISSION INDUCTION; SUPPORT, U.S. GOV'T, P.H.S.; TREATMENT OUTCOME;

EID: 0026580491     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-116-2-114     Document Type: Article

References (32)

1. Austin HA 3d, Klippel JH, Balow JE, le Riche NG, Steinberg AD, Plotz PH, et al. Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. N Engl J Med. 1986;314:614-9.
2. Lewis E, Hunsicker LG, Lan SP, Rohde RD, Lachin JM, Lupus Nephritis Collaborative Study Group. A controlled trial of plasmapheresis therapy in severe lupus nephritis. N Engl J Med. 1992; [In press).
3. Austin HA 3d, Muenz LR, Joyce KM, Antonovych T, Kullick ME, Klippel JH, et al. Prognostic factors in lupus nephritis: Contribution of renal histologic data. Am J Med. 1983;75:382-91.
4. Pollak VE, Pirani CL, Schwartz FD. The natural history of the renal manifestations of systemic lupus erythematosus. J Lab Clin Med. 1964;63:537-50.
5. Baldwin DS, Gluck MC, Lowenstein J, Gallo GR. Lupus nephritis. Clinical course as related to morphologic forms and their transitions. Am J Med. 1977;62:12-30.
6. Appel GB, Silva FG, Pirani CL, Meltzer JI, Estes D. Renal involvement in systemic lupus erythematosus (SLE): a study of 56 patients emphasizing histologic classification. Medicine (Baltimore). 1978;57: 371-410.
7. Whiting-O'Keefe Q, Henke JE, Shearn MA, Hopper J Jr, Biava CG, Epstein WV. The information content from renal biopsy in systemic lupus erythematosus. Stepwise linear regression analysis. Ann Intern Med. 1982;96(Part 1):718-23.
8. Rush PJ, Baumal R, Shore A, Balfe JW, Schreiber M. Correlation of renal histology with outcome in children with lupus nephritis. Kidney Int. 1986;29:1066-71.
9. Magil AB, Puternun ML, Ballon HS, Chan V, Lirenman DS, Rae A, et al. Prognostic factors in diffuse proliferative lupus glomerulonephritis. Kidney Int. 1988;34:511-7.
10. Hecht B, Siegel N, Adler M, Kashgarian M, Hayslett JP. Prognostic indices in lupus nephritis. Medicine (Baltimore). 1976;55:163-81.
11. Cameron JS, Turner DR, Ogg CS, Williams DG, Lessof MH, Chantier C, et al. Systemic lupus with nephritis: a long-term study. Q J Med. 1979;48:1-24.
12. Schwartz MM, Kawala KS, Corwin HL, Lewis EJ. The prognosis of segmental glomerulonephritis in systemic lupus erythematosus. Kidney Int. 1987;32:274-9.
13. Kasinath BK, Neilson EG, Hebert L, Schwartz MM, Lewis EJ, Lupus Nephritis Collaborative Study Group. Short-term prognosis of severe lupus nephritis. Am J Kidney Dis. 1986;8:239-43.
14. Clough JD, Lewis EJ, Lachin JM, Lupus Nephritis Collaborative Study Group. Treatment protocols of the Lupus Nephritis Collaborative Study of plasmapheresis in severe lupus nephritis. In: Rock G; ed. Progress in Clinical and Biological Research: 337. Apheresis: Proceedings of the Second International Congress of the World Apheresis Association. New York: Wiley-Liss. Inc; 1990;301-7.
15. Schwartz MM, Lan SP, Bonsib SM, Gephardt GN, Sharma HM, Lupus Nephritis Collaborative Study Group. Clinical outcome of three discrete histologic patterns of injury in severe lupus glomerulonephritis. Am J Kidney Dis. 1989;13:273-83.
16. Schwartz MM, Bernstein J, Hill GS, Holley K, Phillips E, Lupus Nephritis Collaborative Study Group. Predictive value of renal pathology in diffuse proliferative lupus glomerulonephritis. Kidney Int. 1989;36:891-6.
17. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25:1271-7.
18. Churg J, Sobin LH. Renal Disease: Classification and Atlas of Glomerular Disease. New York: Igaku-Shoin; 1982:127-49.
19. SAS User's Guide; Statistics. Version 5, Edition. SAS Institute Inc., Cary, North Carolina; 1985.
20. BMDP Statistical Software. University of California Press, Berkeley, California; 1988.
21. Fleiss JL. Statistical Methods for Rates and Proportions. New York: John Wiley and Sons; 1981.
22. Randles RH, Wolf DA. Introduction to Theory of Nonparametric Statistics. New York: John Wiley and Sons; 1979.
23. Cox DR. Regression models and life tables. J R Stat Soc. 1972: 34(Series B): 187-220.
24. Snedecor GW, Cochran WG. Statistical Methods. Ames. Iowa. Iowa State University Press; 1980.
25. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. New York: John Wiley and Sons; 1980.
26. Levey AS. Measurement of renal function in chronic renal disease. Kidney Int. 1990;38:167-84.
27. Shemesh O, Golbetz H, Kriss JP, Myers BD. Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int. 1985;28:830-8.
28. Chagnac A, Kiberd BA, Farinas MC, Strober S, Sibley RK, Hoppe R, et al. Outcome of acute glomerular injury in proliferative lupus nephritis. J Clin Invest. 1989;84:922-30.
29. Pollak VE, Pirani CL, Kark RM. Effect of large doses of prednisone on the renal lesions and life span of patients with lupus glomerulonephritis. J Lab Clin Med. 1961;57:495-511.
30. Baldwin DS, Lowenstein J, Rothfield NF, Gallo G, McCluskey RT. The clinical course of the proliferative and membranous forms of lupus nephritis. Ann Intern Med. 1970;73:929-42.
31. Pedersen-Bjergaard J, Ersboll J, Hansen VL, Sorensen BL, Christoffersen K, Hou-Jensen K, et al. Carcinoma of the urinary bladder after treatment with cyclophosphamide for non-Hodgkin's lymphoma. N Engl J Med. 1988;318:1028-32.
32. Travis LB, Curtis RE, Boice JD, Fraumeni JF Jr. Bladder cancer after chemotherapy for non-Hodgkin's lymphoma [Letter]. N Engl J Med. 1989;321:544-5.